We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MuLV-based vectors pseudotyped with truncated HIV glycoproteins mediate specific gene transfer in CD4<sup>+</sup> peripheral blood lymphocytes.
- Authors
Lodge, R; Subbramanian, R A; Forget, J; Lemay, G; Cohen, ÉA
- Abstract
Human immunodeficiency virus (HIV) infection ultimately leads to the destruction of the CD4+ lymphocyte subset and the onset of AIDS. In recent years, several gene therapy procedures making use of retroviral vectors that selectively target HIV susceptible cells have been proposed in order to interfere with HIV productive infection. However, the HIV glycoproteins’ inability to be incorporated in other heterologous retroviruses considerably limits true HIV cell tropism of such vectors. We now report the use of murine leukemia virus (MuLV) viral particles harboring a truncated form of the HIV glycoprotein for specific gene delivery. Reporter lacZ gene transfer was determined to be appropriately specific to CD4+ cells when HeLaCD4 cells or peripheral blood lymphocytes (PBLs) were infected with these pseudotyped MuLV virus vectors. In contrast, MuLV viruses harboring amphotropic MuLV envelope glycoproteins displayed a broad and nonspecific infection of PBL subpopulations. This new approach, taking advantage of the ability of truncated HIV envelope glycoproteins to be incorporated into heterologous retroviral particles, may foreseeably be used in future interventions based on the coordinated delivery of therapeutic gene products specifically to cell types susceptible to HIV infection.
- Subjects
MOUSE leukemia viruses; GENETIC vectors; GLYCOPROTEINS; GENETIC transformation; LYMPHOCYTES
- Publication
Gene Therapy, 1998, Vol 5, Issue 5, p655
- ISSN
0969-7128
- Publication type
Article
- DOI
10.1038/sj.gt.3300646